Managers
TPG Growth, the middle market and growth equity investment platform of TPG, has closed its acquisition of Frank Recruitment Group (FRG), a global staffing and recruiting business focused exclusively on the enterprise software market.
TPG Growth acquired a majority stake in FRG from its founders and UK-based mid-market private equity firm Livingbridge. Livingbridge invested in the Company in 2013 to help it continue to diversify and expand globally.
“We are immensely proud to partner with TPG Growth. They have a history of anticipating trends in technology and investing in some of the most innovative and transformative companies in the world,”
Seabury Group’s recently formed Seabury Global Markets (SGM) entity has made an initial investment and entered into a multi-year, strategic relationship with Spotex, an FX ECN focused on improving foreign exchange and precious metals trading for both buy and sell-side participants.
The new agreement follows the January 2016 announcement of a Joint Product Offering, in which the companies agreed to combine certain products and work together to expand each other’s client base. SGM intends to help develop certain Spotex technology and further grow Spotex’s distribution footprint as part of the Seabury Group of companies.
“We are excited to build on
Fidelity Institutional has expanded its alternative investments platform, which will now provide access to a wide range of private equity funds for all Fidelity Institutional clients.
Fidelity’s alternative investments platform, launched in October 2013, provides research, education and third-party due diligence, as well as access to a wide range of alternative investment products. This expansion of the platform provides financial advisors and family office professionals with increased access to private equity funds through a new strategic relationship with iCapital Network and expanded relationships with CAIS and Goldman Sachs Asset Management (GSAM).
“Delivering increased access to private equity has been a
UK private equity has made a slow start in the first quarter of 2016, following the highest number of buy-outs since 2007, according to figures published by the Centre for Management Buyout Research (CMBOR) at Imperial College Business School.
The latest research, sponsored by Equistone Partners Europe Limited, shows that after positive growth in 2015, buy-outs in the UK were negatively affected by the turmoil in global markets at the start of this year. The first quarter reached the lowest total value since the end of 2009.
In 2015 there was GBP21.1 billion invested in UK buy-outs – the
The recovery rate for private equity transactions – the proportion of capital recovered in any deal where some loss has occurred – continues to maintain record levels of around 80 per cent, according to figures released by CEPRES.
The results come from the new Loss & Recovery Benchmarking in PE.Analyzer, the first platform to benchmark private equity deals, portfolio companies and funds. The analysis is based on investments in 34,743 portfolio companies across 2,235 private equity funds and USD1.5 trillion of capital. The new Loss & Recovery Benchmarking is now available with PE.Analyzer together with performance benchmarking.
“With concern of
An investment subsidiary of Investindustrial is to acquire Valtur Group from its current owners, Sofia which belongs to the Ljuljdjuraj family, who used to control the Valtur Group and will retain a minority shareholding.
The acquisition of Valtur represents the first step of a global project aimed at creating a leading Mediterranean resort operator with Italian roots. The strategy is to consolidate Valtur’s leadership position through the strengthening of its brand presence in the Mediterranean, and by promoting the Italian resort style internationally to increasing numbers of in-bound tourists.
Today Investindustrial has signed two other agreements: with Prelios SGR SpA
Infosys, a specialist in consulting, technology and next-generation services, has partnered with Trifacta to provide a data wrangling solution for the Infosys Information Platform (IIP) and Infosys’ other platforms and offerings.
Infosys clients can now leverage Trifacta’s intuitive self-service solution for exploring and transforming data—a critical step in any analytics process. Business analysts and data scientists can integrate large, complex data sets, transform and filter the results and share valuable insights, all from data stored and processed within the IIP platform.
“Trifacta’s market-leading technology will enable Infosys clients to bring together diverse and disparate data into a more digestible
BlueVine, a leading online provider of everyday financing to small businesses, has secured a strategic investment from Citi Ventures. Financial terms of the investment have not been disclosed.
Citi Ventures' investment will support BlueVine’s growth as it continues to scale its cloud-based working capital financing platform for small businesses and expand into new market segments. Citi Ventures makes strategic investments in dynamic startups and partners with its portfolio companies and Citi's global businesses to accelerate their growth and ability to scale. This represents a follow-on investment to BlueVine’s USD40 million Series C financing in January 2016.
“With a portfolio that
PRA Group, a specialist in acquiring and collecting nonperforming loans, has completed its public tender offer to purchase shares of Warsaw-based DTP SA (DTP) on 26 April, 2016.
Some 99.73 per cent of the shares in DTP have been tendered at PLN 4.90 per share (approximately USD1.26 per share), for an aggregate purchase price of PLN 174.5 million (approximately USD45.0 million). PRA has received all approvals and has filed all notices required for the completion of the tender.
“The DTP acquisition further strengthens PRA Group’s position within the competitive marketplace and provides a fully integrated platform for continued growth in
Merz Pharma has made a strategic venture investment in Cytrellis Biosystems, a US based company developing a new class of non-surgical products to combat sagging skin associated with ageing.
Merz has joined a growing set of industry investors to back Boston-based Cytrellis Biosystems. The investment emphasizes Merz’ strategy to allocate venture investment focused on the areas of anti-ageing, skin rejuvenation and body shaping. And it’s the latest example of Cytrellis’ strategy to selectively attract investors who bring specific aesthetic industry expertise.
“As a young and innovative company with an experienced team, Cytrellis has the potential for a successful market launch
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
